It was reported recently that French drug manufacturer HRA Pharma had found that the emergency contraceptive Norlevo, which has a similar chemical makeup to Plan B One-Step, is ineffective for women over 176 pounds. Here’s why I was not surprised.
A federal court judge Friday refused to grant an extension of time to the U.S. Food and Drug Administration in a long-running case concerning access to emergency contraception.
The debate is characterized by anti-abortion anxiety and aversion to subsidized contraception.
Once again, politics have trumped science, and it’s women and girls who pay the price.
The Obama administration announced it was appealing a federal court order that lifted age-restrictions on the sale of emergency contraception.
The Obama administration’s newest plan to make emergency contraception over-the-counter to some groups and not others only creates more confusion and a new set of barriers to access. I guess this administration would rather play Russian Roulette with teen pregnancy than make it easier to prevent.
Inaccurate arguments posed by anti-choicers against emergency contraception are not about the health and safety of women and girls: Rather, their claims about EC’s safety are proxies for moral disapproval of sex.
The judgment is littered with scathing descriptions of bad faith, politically-motivated maneuvering, and unbelievable wastes of time and taxpayers’ money as well as jaw-dropping legal mistakes—all of which go well beyond the language one expects to find in typical legal opinions.
In a long-awaited decision released early this morning, U.S. District Court Judge Edward Korman ordered the FDA to make emergency contraception available over-the-counter to women of all ages, marking a major win for public health and women’s rights.
It is an outrage that not only may it be difficult to physically access Plan B but also lack of information regarding emergency contraceptives can serve as an obstacle for young women who have been sexually assaulted.